Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. [electronic resource]
Producer: 20020408Description: 594-601 p. digitalISSN:- 1097-6744
- Abciximab
- Antibodies, Monoclonal -- economics
- Coronary Disease -- economics
- Female
- Hospital Costs
- Humans
- Immunoglobulin Fab Fragments -- economics
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Risk Assessment
- Stents -- economics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.